Scientific article

Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature

Published inArchives of dermatological research, vol. 299, no. 4, p. 169-175
Publication date2007

Adverse events triggered by non-steroidal anti-inflammatory drugs (NSAIDs) are among the most common drug-related intolerance reactions in medicine; they are possibly related to inhibition of cyclooxygenase-1. Coxibs, preferentially inhibiting cyclooxygenase-2, may therefore represent safe alternatives in patients with NSAID intolerance. We reviewed the literature in a systematic and structured manner to identify and evaluate studies on the tolerance of coxibs in patients with NSAID intolerance. We searched MEDLINE (1966-2006), the COCHRANE LIBRARY (4th Issue 2006) and EMBASE (1966-2006) up to December 9, 2006, and analysed all publications included using a predefined evaluation sheet. Symptoms and severity of adverse events to coxibs were analysed based on all articles comprising such information. Subsequently, the probability for adverse events triggered by coxibs was determined on analyses of double-blind prospective trials only. Among 3,304 patients with NSAID intolerance, 119 adverse events occurred under coxib medication. All adverse events, except two, have been allergic/urticarial in nature; none was lethal, but two were graded as life-threatening (grade 4). The two non-allergic adverse events were described as a grade 1 upper respiratory tract haemorrhage, and a grade 1 gastrointestinal symptom, respectively. In 13 double-blind prospective studies comprising a total of 591 patients with NSAID intolerance, only 13 adverse reactions to coxib provocations were observed. The triggering coxibs were rofecoxib (2/286), celecoxib (6/208), etoricoxib (4/56), and valdecoxib (1/41). This review documents the good tolerability of coxibs in patients with NSAID intolerance, for whom access to this class of drugs for short-term treatment of pain and inflammation is advantageous.

  • Anti-Inflammatory Agents, Non-Steroidal/adverse effects/therapeutic use
  • Cyclooxygenase 2 Inhibitors/*adverse effects/*therapeutic use
  • Double-Blind Method
  • Gastrointestinal Diseases/chemically induced
  • Hemorrhage/chemically induced
  • Humans
  • Inflammation/*drug therapy
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • Respiratory Tract Diseases/chemically induced
Affiliation Not a UNIGE publication
Citation (ISO format)
WEBERSCHOCK, Tobias Bernd Bernd et al. Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature. In: Archives of dermatological research, 2007, vol. 299, n° 4, p. 169–175. doi: 10.1007/s00403-007-0757-6
Main files (1)
ISSN of the journal0340-3696

Technical informations

Creation09/20/2013 4:48:40 PM
First validation09/20/2013 4:48:40 PM
Update time03/14/2023 8:25:42 PM
Status update03/14/2023 8:25:42 PM
Last indexation02/12/2024 8:32:57 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack